Skip to content

Organon OGN Long-Term Debt

Long-Term Debt at other companies

Pfizer logo
PfizerPFE
$60.57B+5.1%
Amgen logo
AmgenAMGN
$51.89B-3.9%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
$2.46B-4.8%
Biogen logo
BiogenBIIB
$6.29B+38.2%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$2.57B+19.1%
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
$1.44B+11.1%

Other financials

Income statement

See full
Revenue$1.5B-3.5%
Gross profit$783.0M-6.9%
Net income$146.0M+67.8%
EPS (diluted)$0.55+66.7%

Balance sheet

See full
Cash & equivalents$1.1B+104%
Total debt$8.6B-4.3%
Total equity$903.0M+66.6%
Total assets$13.0B-1.2%

Cash flow

See full
Operating cash flow$225.0M+200%
CapEx$37.0M+15.6%
Free cash flow$188.0M+337%

Valuation

See full
Market cap$3.53B-59.4%
Enterprise value$10.98B-26.4%
P/E6.6×+2.1×
P/S0.6×-0.8×

Profitability

See full
Gross margin52.8%-4.4pp
Net margin8%-12.3pp
FCF margin11.1%-1.3pp

Returns & leverage

See full
Return on equity71.6%
Debt / equity9.5×-7.0×
Current ratio+0.3×

Where this comes from

Reported directly by Organon in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtNoncurrent.

The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organon's long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organon's long-term debt?
Organon (OGN) reported long-term debt of $8.55B in Q1 2026.
How has Organon's long-term debt changed year-over-year?
Organon's long-term debt decreased by 4.3% year-over-year, from $8.94B to $8.55B.
What does long-term debt mean?
Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.